Catheter to Thermally Classify Atherosclerotic Plaque

Information

  • Research Project
  • 6403011
  • ApplicationId
    6403011
  • Core Project Number
    R43HL067473
  • Full Project Number
    1R43HL067473-01A1
  • Serial Number
    67473
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/2001 - 23 years ago
  • Project End Date
    7/31/2002 - 22 years ago
  • Program Officer Name
    CHEUNG, GEOFFREY P.
  • Budget Start Date
    8/1/2001 - 23 years ago
  • Budget End Date
    7/31/2002 - 22 years ago
  • Fiscal Year
    2001
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    8/1/2001 - 23 years ago

Catheter to Thermally Classify Atherosclerotic Plaque

DESCRIPTION (provided by applicant): Unstable plaque is well established as producing high risk for sudden myocardial infarction (MI), through plaque rupture and subsequent thrombotic response, or thrombosis generated at the inflamed plaque surface. It cannot be located by angiography, and has been estimated to account for 60-70 percent of fatal MIs and up to 85 percent of all MIs. Accumed Systems, Inc. will develop a Thermal Sensing Catheter (TSC) to identify unstable plaque. Such measurements have been made in research labs, but no such product now exists. Technological innovation to achieve this includes developing new micro-thermistor and specialized manufacturing techniques to embed them in sensing arms, as well as developing new and novel testing techniques. It will measure the surface temperature of the inner wall of coronary arteries at multiple sites and identify sites of unstable plaque. Specific aims: 1) Prove the viability of intra-arterial measurements by making repeated measurements of simulated hot spots in canine arteries with prototype catheters. Demonstrate meeting preliminary spatial, thermal, and temporal specifications. 2) Confirm the functionality of the design and generate prototypes for the next round of tests on atherosclerotic rabbits to take place in Phase II. PROPOSED COMMERCIAL APPLICATION: The Thermal Sensing Catheter (TSC) to be developed will have immediate commercial applications in the large (est. $200 million/year) market for atherosclerotic plaque stability assessment. The underlying technology will also have a wide range of other cardiovascular applications where inflammation is present, e.g. myocarditis, valvulitis, aortis, as well as in those in other areas about to be biopsied, such as skin lesions, gingival lesions and urinary bladder.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ACCUMED SYSTEMS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    ANN ARBOR
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    481039140
  • Organization District
    UNITED STATES